These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Silber S; Albertsson P; Avilés FF; Camici PG; Colombo A; Hamm C; Jørgensen E; Marco J; Nordrehaug JE; Ruzyllo W; Urban P; Stone GW; Wijns W; Eur Heart J; 2005 Apr; 26(8):804-47. PubMed ID: 15769784 [TBL] [Abstract][Full Text] [Related]
4. [Percutaneous transluminal coronary angioplasty for treatment of coronary disease]. Witkowski A; Poloński L Kardiol Pol; 2005 Nov; 63(5 Suppl 3):S509-42. PubMed ID: 20527387 [No Abstract] [Full Text] [Related]
5. Updated guidelines for percutaneous coronary intervention: what are the most important changes? Spencer BK; Smith SC Pol Arch Med Wewn; 2008 Mar; 118(3):96-7. PubMed ID: 18476453 [No Abstract] [Full Text] [Related]
8. [Oral glycoprotein IIb/IIIa-inhibitors inhibit platelet aggregation: an aid against unstable coronary syndrome and recurrent stenosis after angioplasty. Satellite symposia within the 22nd Congress of the European Cardiology Society]. Dtsch Med Wochenschr; 1998 Oct; 123(44 Suppl):1-6. PubMed ID: 9828729 [No Abstract] [Full Text] [Related]
9. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Hamm CW; Bassand JP; Agewall S; Bax J; Boersma E; Bueno H; Caso P; Dudek D; Gielen S; Huber K; Ohman M; Petrie MC; Sonntag F; Uva MS; Storey RF; Wijns W; Zahger D; Eur Heart J; 2011 Dec; 32(23):2999-3054. PubMed ID: 21873419 [No Abstract] [Full Text] [Related]
10. Facilitated percutaneous coronary intervention: a novel concept in expediting and improving acute myocardial infarction care. Li RH; Herrmann HC Am Heart J; 2000 Dec; 140(6 Suppl):S125-35. PubMed ID: 11100006 [No Abstract] [Full Text] [Related]
11. Glycoprotein IIb/IIIa inhibitors: current indications and future prospects. Reginelli JP; Topol EJ Am J Med; 2000 Aug; 109(3):252-4. PubMed ID: 10974193 [No Abstract] [Full Text] [Related]
12. The year in interventional cardiology. Dixon SR; Grines CL; O'Neill WW J Am Coll Cardiol; 2010 May; 55(20):2272-86. PubMed ID: 20466207 [No Abstract] [Full Text] [Related]
14. Introduction: glycoprotein IIb/IIIa blockers in the era of metallic coronaries. Goldschmidt-Clermont PJ J Invasive Cardiol; 2002 Dec; 14 Suppl E():1E. PubMed ID: 12668856 [No Abstract] [Full Text] [Related]
15. [Clopidogrel should be added to aspirin for at least 1 year after percutaneous coronary interventions (CREDO) while before them its loading dose can reach 600mg (ISAR-COOL)]. Gratsianskiĭ NA Kardiologiia; 2003; 43(5):71-3. PubMed ID: 12942928 [No Abstract] [Full Text] [Related]
16. Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb/IIIa blockade compared to heparin with routine glycoprotein IIb/IIIa blockade: a REPLACE-2 substudy. Saw J; Lincoff AM; DeSmet W; Betriu A; Rutsch W; Wilcox RG; Kleiman NS; Wolski K; Topol EJ; J Am Coll Cardiol; 2004 Sep; 44(6):1194-9. PubMed ID: 15364319 [TBL] [Abstract][Full Text] [Related]
17. GP IIb/IIIa inhibitors in coronary artery disease management: what the latest trials tell us. Chew DP; Moliterno DJ Cleve Clin J Med; 2001 Dec; 68(12):1017-23. PubMed ID: 11765119 [TBL] [Abstract][Full Text] [Related]
18. [Advances in adjunctive pharmacological therapy for percutaneous coronary interventions]. Benito B; Masotti M; Betriu A Rev Esp Cardiol; 2005 Jun; 58(6):729-43. PubMed ID: 15970124 [TBL] [Abstract][Full Text] [Related]
19. Safe use of platelet GP IIb/IIIa inhibitors. Ferguson JJ; Kereiakes DJ; Adgey AA; Fox KA; Hillegass WB; Pfisterer M; Vassanelli C Eur Heart J; 1998 Apr; 19 Suppl D():D40-51. PubMed ID: 9597521 [TBL] [Abstract][Full Text] [Related]
20. Role of enoxaparin in the invasive management of the ACS patient. Hermiller JB J Invasive Cardiol; 2004 Feb; 16(2):52-3. PubMed ID: 14760189 [No Abstract] [Full Text] [Related] [Next] [New Search]